{"id":"https://openalex.org/W2004111147","doi":"https://doi.org/10.1034/j.1600-0463.2002.100403.x","title":"Conditions influencing the in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida: Impact on the development of buccal preparations of lactoferrin","display_name":"Conditions influencing the in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida: Impact on the development of buccal preparations of lactoferrin","alternate_titles":[],"publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W2004111147","doi":"https://doi.org/10.1034/j.1600-0463.2002.100403.x","mag":"2004111147","pmid":"https://pubmed.ncbi.nlm.nih.gov/12076264"},"language":"en","primary_location":{"id":"doi:10.1034/j.1600-0463.2002.100403.x","doi":"https://doi.org/10.1034/j.1600-0463.2002.100403.x","is_oa":false,"landing_page_url":"https://doi.org/10.1034/j.1600-0463.2002.100403.x","pdf_url":null,"source":{"id":"https://openalex.org/S135377718","display_name":"Apmis","issn_l":"0903-4641","issn":["0903-4641","1600-0463"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"APMIS","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2004111147"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042423012","display_name":"Mirjam E. Kuipers","orcid":"https://orcid.org/0009-0009-1536-7079","observed_orcids":["https://orcid.org/0009-0009-1536-7079"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. E. Kuipers","raw_affiliation_strings":["Groningen University Institute for Drug Exploration (GUIDE), Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen, The Netherlands","# current affiliation: Yamanouchi Europe B.V., Leiderdorp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groningen University Institute for Drug Exploration (GUIDE), Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"# current affiliation: Yamanouchi Europe B.V., Leiderdorp, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078081558","display_name":"Leonie Beljaars","orcid":"https://orcid.org/0000-0003-3659-1896","observed_orcids":["https://orcid.org/0000-0003-3659-1896"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"L. Beljaars","raw_affiliation_strings":["Groningen University Institute for Drug Exploration (GUIDE), Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groningen University Institute for Drug Exploration (GUIDE), Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen,","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033289884","display_name":"Nina van Beek","orcid":"https://orcid.org/0000-0002-3265-0011","observed_orcids":["https://orcid.org/0000-0002-3265-0011"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Van Beek","raw_affiliation_strings":["Numico Research B.V., Wageningen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Numico Research B.V., Wageningen,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049653769","display_name":"Hendrik G. de Vries","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H. G. De Vries","raw_affiliation_strings":["University Hospital Groningen, Section of Medical Microbiology, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Groningen, Section of Medical Microbiology, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111627382","display_name":"Janette Heegsma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. Heegsma","raw_affiliation_strings":["Groningen University Institute for Drug Exploration (GUIDE), Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groningen University Institute for Drug Exploration (GUIDE), Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen,","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077818538","display_name":"Jeroen J.M. van den Berg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. J. M. Van Den Berg","raw_affiliation_strings":["Numico Research B.V., Wageningen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Numico Research B.V., Wageningen,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057782919","display_name":"D. K. F. Meijer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"D. K. F. Meijer","raw_affiliation_strings":["Groningen University Institute for Drug Exploration (GUIDE), Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groningen University Institute for Drug Exploration (GUIDE), Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen,","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064633308","display_name":"P. J. Swart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"P. J. Swart","raw_affiliation_strings":["# current affiliation: Yamanouchi Europe B.V., Leiderdorp, The Netherlands","Groningen University Institute for Drug Exploration (GUIDE), Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"# current affiliation: Yamanouchi Europe B.V., Leiderdorp, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"Groningen University Institute for Drug Exploration (GUIDE), Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen,","institution_ids":["https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5078081558"],"corresponding_institution_ids":["https://openalex.org/I169381384"],"apc_list":{"value":4460,"currency":"USD","value_usd":4460},"apc_paid":null,"fwci":1.2277,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.77695117,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"110","issue":"4","first_page":"290","last_page":"298"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10225","display_name":"Essential Oils and Antimicrobial Activity","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1106","display_name":"Food Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lactoferrin","display_name":"lactoferrin","score":1.0},{"id":"https://openalex.org/keywords/candida","display_name":"Candida","score":0.9190000295639038},{"id":"https://openalex.org/keywords/oropharyngeal-candidiasis","display_name":"oropharyngeal candidiasis","score":0.9279999732971191},{"id":"https://openalex.org/keywords/antifungal-activity","display_name":"antifungal activity","score":0.9580000042915344},{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.8240000009536743},{"id":"https://openalex.org/keywords/amphotericin-b","display_name":"amphotericin B","score":1.0},{"id":"https://openalex.org/keywords/synergistic-drug-combination","display_name":"synergistic drug combination","score":0.574999988079071},{"id":"https://openalex.org/keywords/medium-ph","display_name":"medium pH","score":0.4020000100135803},{"id":"https://openalex.org/keywords/saliva","display_name":"saliva","score":0.8849999904632568},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.7379999756813049},{"id":"https://openalex.org/keywords/minimum-inhibitory-concentration","display_name":"minimum inhibitory concentration","score":0.7319999933242798}],"concepts":[{"id":"https://openalex.org/C2779170986","wikidata":"https://www.wikidata.org/wiki/Q410246","display_name":"Lactoferrin","level":2,"score":0.9905120134353638},{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.7795687317848206},{"id":"https://openalex.org/C2779629538","wikidata":"https://www.wikidata.org/wiki/Q412223","display_name":"Amphotericin B","level":3,"score":0.6974920034408569},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6395256519317627},{"id":"https://openalex.org/C504460877","wikidata":"https://www.wikidata.org/wiki/Q155925","display_name":"Saliva","level":2,"score":0.5541813969612122},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5496606826782227},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5017514228820801},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.5005123615264893},{"id":"https://openalex.org/C2777762789","wikidata":"https://www.wikidata.org/wiki/Q251005","display_name":"Nystatin","level":3,"score":0.4918113052845001},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3794877529144287},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3385523557662964},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18064850568771362}],"mesh":[{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002175","descriptor_name":"Candida","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002175","descriptor_name":"Candida","qualifier_ui":"Q000254","qualifier_name":"growth & development","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003470","descriptor_name":"Culture Media","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007781","descriptor_name":"Lactoferrin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012471","descriptor_name":"Salivary Proteins and Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1034/j.1600-0463.2002.100403.x","doi":"https://doi.org/10.1034/j.1600-0463.2002.100403.x","is_oa":false,"landing_page_url":"https://doi.org/10.1034/j.1600-0463.2002.100403.x","pdf_url":null,"source":{"id":"https://openalex.org/S135377718","display_name":"Apmis","issn_l":"0903-4641","issn":["0903-4641","1600-0463"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"APMIS","raw_type":"journal-article"},{"id":"pmid:12076264","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12076264","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/8500bd91-25df-4741-be07-6d5d625bfce2","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/8500bd91-25df-4741-be07-6d5d625bfce2","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kuipers, ME, Beljaars, L, Van Beek, N, De Vries, HG, Heegsma, J, Van Den Berg, JJM, Meijer, DKF & Swart, PJ 2002, 'Conditions influencing the in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida - Impact on the development of buccal preparations of lactoferrin', APMIS, vol. 110, no. 4, pp. 290-298.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/8500bd91-25df-4741-be07-6d5d625bfce2","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/8500bd91-25df-4741-be07-6d5d625bfce2","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"APMIS, 110(4), 290 - 298","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W137721614","https://openalex.org/W160525882","https://openalex.org/W1508362700","https://openalex.org/W1531531679","https://openalex.org/W1964271418","https://openalex.org/W2030827652","https://openalex.org/W2040310992","https://openalex.org/W2041901346","https://openalex.org/W2047418663","https://openalex.org/W2084574757","https://openalex.org/W2090968765","https://openalex.org/W2095271275","https://openalex.org/W2106426214","https://openalex.org/W2106463998","https://openalex.org/W2119900141","https://openalex.org/W2122577468","https://openalex.org/W2123559285","https://openalex.org/W2127773112","https://openalex.org/W2131724400","https://openalex.org/W2137424020","https://openalex.org/W2144541214","https://openalex.org/W2158124451","https://openalex.org/W2165260654","https://openalex.org/W2976538948"],"related_works":["https://openalex.org/W2123559285","https://openalex.org/W4417358419","https://openalex.org/W1461960487","https://openalex.org/W2921274204","https://openalex.org/W2044566419","https://openalex.org/W1974231024","https://openalex.org/W4293117574","https://openalex.org/W1965015032","https://openalex.org/W2004210352"],"abstract_inverted_index":{"Lactoferrin,":[0],"an":[1],"iron-binding":[2],"glycoprotein,":[3],"is":[4,183],"a":[5,55,170,212],"potential":[6],"agent":[7,94],"for":[8,101,141,165],"the":[9,17,23,37,52,83,91,104,126,130,152,158,181,193],"treatment":[10,166],"of":[11,16,25,39,49,54,64,72,114,119,129,143,151,160,167],"oropharyngeal":[12],"Candidiasis.":[13],"The":[14,61,117,196],"aim":[15],"present":[18],"study":[19],"was":[20],"to":[21,35,47,88,121,188],"test":[22],"capability":[24],"lactoferrin,":[26,102],"combined":[27,30],"or":[28,147,157],"not":[29,110,124],"with":[31,185],"conventional":[32],"antifungal":[33,93,127],"agents,":[34],"inhibit":[36],"growth":[38,138],"different":[40],"Candida":[41,137],"species":[42],"under":[43],"various":[44],"experimental":[45],"conditions":[46],"be":[48,178,208],"guidance":[50],"in":[51,192,210],"development":[53],"suitable":[56],"pharmaceutical":[57],"formulation":[58,171,182],"containing":[59,172],"lactoferrin.":[60],"anti-Candida":[62],"activities":[63,128],"lactoferrin":[65,144,173,200],"were":[66,78,98,139],"considerably":[67],"higher":[68],"using":[69],"RPMI":[70],"instead":[71],"SLM":[73],"as":[74,100],"assay":[75],"medium.":[76],"They":[77],"moreover":[79],"increased":[80],"by":[81],"raising":[82],"medium":[84,105,122,153],"pH":[85,108,190],"from":[86],"5.6":[87],"7.5.":[89],"With":[90],"'standard'":[92,202],"fluconazole":[95,146],"similar":[96],"results":[97,176],"found":[99,140],"but":[103],"type":[106,154],"and":[107,145,155,201],"did":[109,123],"affect":[111],"MIC":[112],"values":[113],"amphotericin":[115,148],"B.":[116],"addition":[118,159],"saliva":[120],"reduce":[125],"individual":[131],"compounds.":[132],"Synergistic":[133],"inhibitory":[134],"effects":[135,198],"on":[136],"combinations":[142,206],"B,":[149],"irrespective":[150],"pH,":[156],"saliva.":[161],"This":[162],"indicates":[163],"that":[164,205],"oral":[168],"Candidiasis":[169],"seems":[174],"appropriate;":[175],"may":[177],"optimized":[179],"if":[180],"provided":[184],"buffer":[186],"capacity":[187],"attain":[189],"7.5":[191],"mucosal":[194],"fluid.":[195],"synergistic":[197],"between":[199],"antifungals":[203],"indicate":[204],"should":[207],"considered":[209],"such":[211],"formulation.":[213]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2004111147","counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
